Bezlotoxumab Not Yet Recruiting Phase 4 Trials for Clostridia Difficile Colitis / Clostridium; Sepsis Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03756454Comparing the Effectiveness of IV Bezlotoxumab Versus Placebo in Decreasing Morbidity and Mortality in Patients With Fulminant C. Diff Requiring Surgery.